Alkermes (ALKS) EV to FCF (2010 - 2026)
Alkermes' (ALKS) quarterly EV to FCF came in at 59.27 in Q2 2026, up 119.38% year-over-year from 27.02 in Q2 2025, and up 287.31% quarter-over-quarter from 31.64 in Q1 2026.
Analysis
Alkermes (ALKS) EV to FCF (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has reported EV to FCF for 17 consecutive years, with 59.27 the latest figure, recorded in Q2 2026.
- On a quarterly basis, EV to FCF rose 119.38% year-over-year to 59.27 in Q2 2026; TTM through Jun 2026 was 36.65, a 374.42% increase from a year earlier, with the FY2025 full-year figure at 7.32, down 24.15% from the prior year.
- EV to FCF was 59.27 for Q2 2026 at Alkermes, up from 31.64 in the prior quarter.
- Over five years, EV to FCF peaked at 300.39 in Q1 2024 and troughed at 410.5 in Q4 2022.
- A 5-year average of 15.27 and a median of 24.74 in 2024 frame the typical range for EV to FCF.
- The widest YoY moves for EV to FCF: up 687.64% in 2022, down 652.4% in 2022.
- Over 5 years, EV to FCF stood at 410.5 in 2022, then surged by 110.42% to 42.77 in 2023, then tumbled by 49.36% to 21.66 in 2024, then slipped by 4.63% to 20.66 in 2025, then soared by 186.91% to 59.27 in 2026.
- The last three EV to FCF figures came in at 59.27 (Q2 2026), 31.64 (Q1 2026), and 20.66 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 644.32 Bn | 623.56 Bn | 17.26 Bn |
| 2 | AbbVie | 440.60 Bn | 434.04 Bn | 12.70 Bn |
| 3 | Merck | 365.39 Bn | 358.25 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn |
| 5 | Pfizer | 159.22 Bn | 147.52 Bn | 10.94 Bn |
| 6 | Sanofi | 52.48 Bn | 45.10 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.21 Bn | 44.21 Bn | - |
| 8 | Incyte | 25.34 Bn | 20.81 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.49 Bn | 18.82 Bn | 683.80 Mn |
| 10 | Alkermes | 7.58 Bn | 6.93 Bn | 397.90 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 59.27 |
| Mar 31, 2026 | -31.64 |
| Dec 31, 2025 | 20.66 |
| Sep 30, 2025 | 45.54 |
| Jun 30, 2025 | 27.02 |
| Mar 31, 2025 | 51.40 |
| Dec 31, 2024 | 21.66 |
| Sep 30, 2024 | 49.36 |
| Jun 30, 2024 | 22.47 |
| Mar 31, 2024 | 300.39 |
| Dec 31, 2023 | 42.77 |
| Sep 30, 2023 | 44.34 |
| Jun 30, 2023 | 21.27 |
| Mar 31, 2023 | -144.90 |
| Dec 31, 2022 | -410.50 |
| Sep 30, 2022 | -313.61 |
| Jun 30, 2022 | -351.44 |
| Mar 31, 2022 | 271.13 |
| Dec 31, 2021 | 144.47 |
| Sep 30, 2021 | 56.77 |